Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2001 | 09-2001 | 06-2001 | 03-2001 | 12-2000 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 52,271 | -79,306 | -54,110 | -21,723 | -56,776 |
| Depreciation Amortization | 14,691 | 10,846 | 7,053 | 3,445 | 12,008 |
| Accounts receivable | -25,482 | -8,152 | -7,168 | -6,030 | -3,942 |
| Accounts payable and accrued liabilities | 8,454 | 3,656 | 541 | -1,600 | 2,232 |
| Other Working Capital | -30,822 | -14,897 | -17,408 | -12,489 | -6,617 |
| Other Operating Activity | -146,091 | -4,909 | 9,429 | 8,149 | 14,893 |
| Operating Cash Flow | $-126,979 | $-92,762 | $-61,663 | $-30,248 | $-38,202 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -97,191 | -81,239 | -90,269 | -87,748 | -66,132 |
| PPE Investments | 103,669 | -16,659 | -11,037 | -3,254 | -15,621 |
| Purchase Of Investment | N/A | N/A | N/A | N/A | -2,450 |
| Sale Of Investment | 14,300 | 14,300 | N/A | N/A | N/A |
| Investing Cash Flow | $20,778 | $-83,598 | $-101,306 | $-91,002 | $-84,203 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 241,750 |
| Debt Repayment | -2,761 | -2,053 | -1,252 | -477 | -3,156 |
| Common Stock Issued | 36,311 | 18,885 | 14,364 | 1,900 | 30,451 |
| Financing Cash Flow | $33,550 | $16,832 | $13,112 | $1,423 | $269,045 |
| Exchange Rate Effect | -1,151 | -418 | -514 | -62 | 3,641 |
| Beginning Cash Position | 197,292 | 197,292 | 197,292 | 197,292 | 47,011 |
| End Cash Position | 123,490 | 37,346 | 46,921 | 77,403 | 197,292 |
| Net Cash Flow | $-73,802 | $-159,946 | $-150,371 | $-119,889 | $150,281 |
| Free Cash Flow | |||||
| Operating Cash Flow | -126,979 | -92,762 | -61,663 | -30,248 | -38,202 |
| Capital Expenditure | -26,331 | -16,659 | -11,037 | -3,254 | -15,621 |
| Free Cash Flow | -153,310 | -109,421 | -72,700 | -33,502 | -53,823 |